The aim of the expert council "First star duo of telmisartan and indapamide in the Russian Federation", dedicated to the introduction of a new fixed-dose combination of telmisartan and indapamide (modified-release tablets) into clinical practice was to formulate an expert opinion on the potential use of novel fixed-dose combination of telmisartan and indapamide in the treatment of hypertensive patients
